\u00a0Ain Alalam – Rashad Iskandrni<\/strong><\/p>\n Royal Philips<\/a> (NYSE: PHG, AEX: PHIA), a global leader in health technology, is unveiling a suite of AI-powered innovations at the World Health Expo (WHX) Dubai 2026<\/a> to meet the region’s accelerating demand for smarter, faster and more sustainable care.<\/p>\n The UAE\u2019s healthcare sector is ready for this transformation. In the 2025 Philips Health Trends Research UAE<\/a>, 77% of residents are confident in AI\u2019s ability to enhance healthcare delivery – from diagnosis and treatment planning to operational efficiency. This confidence extends to virtual care with 79% of UAE residents expressing positive sentiment toward telehealth and e-health solutions. In parallel, sustainability is influencing patient decisions more than ever, with 83% of respondents more likely to choose providers that champion environmentally responsible practices.<\/p>\n \n Building on Philips\u2019 established presence and partnerships across the Middle East, T\u00fcrkiye and Africa (META), the company is meeting the region\u2019s readiness through action, delivering innovations that harness AI to streamline workflows, bring diagnostic care closer to patients, and operate more sustainably at every level.<\/p>\n \n “This region is not waiting for healthcare transformation – it’s driving it,” says Tamer Said<\/a>, General Manager, Health Systems, Philips Gulf & Levant and West Africa. “What we’re showcasing at WHX Dubai 2026 reflects that leadership: solutions designed to give time back to clinicians and patients, and a connected portfolio that enables health systems to deliver better care for more people.”<\/p>\n Making their regional debut at WHX Dubai 2026 are breakthrough innovations in MR, CT, mobile X-ray and point-of-care ultrasound, alongside Philips’ broader connected portfolio spanning healthcare informatics, patient monitoring, Image-Guided Therapy and Sleep & Respiratory Care.<\/p>\n World-First Imaging Innovations<\/strong><\/p>\n Philips is unveiling two flagship diagnostic imaging innovations for the first time in the region that leverage AI to eliminate traditional trade-offs between speed, image quality and sustainability.<\/p>\n \n Philips BlueSeal Horizon<\/a>[1]<\/a> – an entirely new 3.0T MRI platform that includes the world\u2019s first helium-free[2]<\/a> 3.0T magnet. A pivotal advance in MRI innovation, helium-free 3.0T is a major scientific achievement set to bring next-generation clinical AI into everyday practice.<\/p>\n \n \u201cBlueSeal Horizon\u2019s helium-free magnet not only reduces siting complexity, installation time and total lifecycle risk \u2013 it also introduces breakthrough AI-powered software that overcomes the traditional compromise between imaging speed and precision, improving outcomes for patients, practitioners and the planet[3]<\/a>,\u201d says Said<\/a>.<\/p>\n \n Clinical AI innovations on the BlueSeal Horizon platform will:<\/p>\n \n Also being shown for the first time in the region at WHX Dubai is Verida<\/a>[5]<\/a> – the world’s first detector-based spectral CT fully powered by AI. Built on more than a decade of clinical experience, with over 800 global installations and supported by over 800 peer-reviewed publications[6]<\/a>, Philips’ spectral CT technology<\/a> has been fully embedded into clinical workflows.<\/p>\n \n Verida integrates AI across the imaging chain, from acquisition to reconstruction, generating superior spectral image quality with minimal noise. It reconstructs 145 images per second, delivering entire exams automatically in less than 30 seconds – enabling up to 270 exams every day[7]<\/a>. With its full AI capabilities, Verida can achieve dramatic dose reduction[8]<\/a> without compromising image quality and reduce energy consumption by up to 45%.[9]<\/a><\/p>\n \n “Combining the latest advances in our proven spectral CT technology with AI, our flagship Verida CT system is designed to set a new standard in superior image quality and accelerated scans which are fully embedded in the radiology workflow \u2014 helping clinicians detect and characterize disease earlier, reduce variability in diagnoses, and support efficient treatment pathways, in a single scan,” says Said.<\/p>\n \u00a0<\/strong><\/p>\n Diagnostic Precision to the Point of Care<\/strong><\/p>\n To meet the demands of the UAE\u2019s expanding healthcare system, Philips is showcasing advanced point-of-care solutions that deliver diagnostics directly to patients.<\/p>\n \n Philips Radiography 7000 M –<\/a> a premium mobile X-ray system, uses smart automation and AI to reduce physical strain on staff and increase patient throughput by up to 37%,[10]<\/sup><\/a>,[11]<\/a><\/sup> supporting the region\u2019s priorities for healthcare access and efficiency.<\/p>\n \n \u00a0Flash 5100 Point of Care<\/a> Ultrasound – combines exceptional image clarity, smart automation, and a portable vertical design with intuitive touchscreen controls. It allows clinicians to perform and document exams in real time, ideal for high-pressure environments.<\/p>\n \n Philips Transcend Plus<\/a> Release\u00a0in echocardiography, and\u00a0Elevate Release<\/a>\u00a0in General Imaging and OBGYN. Building on the Transcend platform, it integrates AI and intelligent automation into EPIQ CVx<\/a> and Affiniti CVx<\/a> cardiovascular ultrasound systems, delivering fast, reproducible results with high image quality and enhanced decision support.<\/p>\n \n “Transcend Plus is one solution that delivers on healthcare providers\u2019 belief that AI can reduce the burden of cardiovascular disease[12]<\/a>,” says Said. \u201cThe system streamlines workflows and improves diagnostic accuracy across care settings – from echo labs to outpatient clinics and long-term care – helping cardiology teams work more efficiently, without compromising quality.\u201d<\/p>\n \n Across the portfolio, Collaboration Live<\/a>\u00a0enables secure, real-time remote specialist guidance from any Philips ultrasound system, while shared interfaces and compatible transducers eliminate learning curves between systems – addressing workflow challenges and ensuring uniform diagnostic capabilities from major hospitals to community clinics for better patient care.<\/p>\n \n Connected Healthcare Ecosystem across Care Settings<\/strong><\/p>\n Complementing these flagship innovations, Philips is showcasing its comprehensive solutions portfolio designed to support coordinated care pathways across the region\u2019s diverse healthcare ecosystem. The showcase includes:<\/p>\n \n \n “The UAE’s healthcare transformation is gathering momentum, and the innovations we’re unveiling at WHX Dubai are designed to accelerate it,” says Said. “By connecting care across settings, embedding AI into clinical workflows, and designing for sustainability, we’re helping healthcare teams deliver predictive, personalized care – and giving them back time to focus on patients.\u201d<\/p>\n \u00a0<\/strong><\/p>\n ENDS<\/strong><\/p>\n \n World Health Expo (WHX) Dubai 2026 is taking place at the Dubai Exhibition Centre<\/strong> from February 9 – 12, 2026. Visit the Philips booth<\/strong> at Stand N21.J10<\/strong>.<\/p>\n \n For more information or to book time with one of our Philips Lifecycle Solutions experts, visit the Philips at WHX 2026 webpage<\/a> and follow @PhilipsME<\/strong> on X (Twitter)<\/em> for live #WHXDubai2026 updates.<\/p>\n \u00a0<\/strong><\/p>\n About Royal Philips<\/strong><\/p>\n Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people\u2019s health and well-being through meaningful innovation. Philips\u2019 patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately\u00a067,000 employees with sales and services in more than 100 countries. News about Philips can be found at\u00a0www.philips.com\/newscenter<\/a><\/p>\n \n [1]<\/a> BlueSeal Horizon Platform is \u2018Work in Progress\u2019 and not available in any jurisdiction. Its future availability cannot be ensured<\/p>\n [2]<\/a> Helium-free operations. 7 liters of helium is permanently enclosed in the cryogenic circuit.<\/p>\n [3]<\/a> Philips has led the development of helium-free MRI since 2018, with more than 2,000 of its 1.5T BlueSeal MRI systems installed worldwide, saving more than 6 million liters of liquid helium to date. The amount of liquid helium saved is a calculation compared to a previous generation magnet with 1500 liters of helium.<\/p>\n [4]<\/a> Compared to Philips SENSE\/ C-SENSE imaging SmartSpeed Precise is already available on current 3.0T systems.<\/p>\n [5]<\/a> CE marked and 510(k) pending. Not available for sale in the United States.<\/p>\n [6]<\/a> Data on file.<\/p>\n [7]<\/a> Spectral CT Verida Premium up to 270 (4 CIRS config) exams a day (16 hours dual shift working day) meeting the needs of radiology departments with extended work hours and very high patient throughput.<\/p>\n [8]<\/a> Dose reduction assessments were performed using reference body protocol. In clinical practice, the use of Spectral Precise Image may reduce CT patient dose depending on the clinical task, patient size, and anatomical location. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.<\/p>\n [9]<\/a> Based on Axial Body 3D Scan with 80% dose reduction. Energy savings for system preparation is not included.<\/p>\n [10]<\/a> As compared to Radiography 5700 M \u2014 MobileDiagnost wDR<\/p>\n [11]<\/a> Validated by 15 out of 15 technologists in a test environment<\/p>\n [12]<\/a> Philips FHI 2025 Cardiology Snapshot | Philips<\/a><\/p>\n [13]<\/a> Device must be capable of data output and system must be able to receive HL7.<\/p>\n [14]<\/a> PIPS enables iSyntax files and with the Software Development Kit (SDK) third-party companies can use this for AI capabilities.<\/p>\n [15]<\/a> Results from study conducted at St. Antonius Hospital. Results verified by NAMSA, independent third-party expert on study design and analytics. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.<\/p>\n [16]<\/a> Tscholl DW, Handschin L, Neubauer P, et al. Using an animated patient avatar to improve perception of vital sign information by anaesthesia professionals. Br J Anaesth. 2018;121(3):662-671. doi:10.1016\/j.bja.2018.04.024<\/p>\n![\"\"](\"https:\/\/ainalalam.com\/wp-content\/uploads\/2026\/02\/Tamer-Said_-Philips-257x300.jpg\")
<\/strong><\/p>\n\n
\n